Literature DB >> 16001650

Immunohistochemical study of hepatic angiomyolipoma.

Chun-Nan Yeh1, Kam-Fai Lee, Miin-Fu Chen.   

Abstract

BACKGROUND/AIMS: Angiomyolipoma (AML), a rare benign tumor, occurs in the liver and other organs. The hormonal role in genesis and development of HAML is unknown. We performed an immunohistochemical study on 12 female cases to detect estrogen and progesterone receptors (ER, PR) to elucidate the hormonal role in this tumor.
METHODOLOGY: Medical records of the 12 patients with hepatic angiomyolipoma (HAML) treated at the Chang Gung Memorial Hospital-Taipei between Oct 1988 and Oct 2000 were retrospectively reviewed. An immunohistochemical study was performed on these twelve patients with ER, PR, and HMB-45.
RESULTS: Twelve female patients with HAML were identified with ages ranging from 28 to 66 years. Abdominal pain was the most frequent symptom. HMB-45 was positive in all the twelve patients. ER and PR were negative in all cases.
CONCLUSIONS: HMB-45 special staining could be regarded as a diagnostic criterion for HAML. Sex hormone may play no role in the pathogenesis and growth of the HAML. Hormonal therapy also plays no role in the management of the tumor. Its prognosis is favorable regardless of management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16001650

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases.

Authors:  Xiaoyu Yang; Aijun Li; Mengchao Wu
Journal:  Med Oncol       Date:  2013-01-06       Impact factor: 3.064

Review 2.  Myomatous hepatic angiomyolipoma: imaging findings in 14 cases with radiological-pathological correlation and review of the literature.

Authors:  Z Zhu; L Yang; X-M Zhao; D-Q Luo; H-T Zhang; C-W Zhou
Journal:  Br J Radiol       Date:  2014-03-27       Impact factor: 3.039

3.  Hepatic angiomyolipoma: a clinical experience in diagnosis and treatment.

Authors:  Jian-Ping Zeng; Jia-Hong Dong; Wen-Zhi Zhang; Jing Wang; Xiao-Ping Pang
Journal:  Dig Dis Sci       Date:  2010-02-18       Impact factor: 3.199

4.  Diagnosis and treatment of hepatic angiomyolipoma.

Authors:  Shunda Du; Ying Li; Yilei Mao; Xinting Sang; Xin Lu; Wenze Wang; Qing Zhang; Huadan Xue; Xiaobo Yang; Shaohua Li; Tianyi Chi; Shouxian Zhong; Jiefu Huang
Journal:  Hepatobiliary Surg Nutr       Date:  2012-12       Impact factor: 7.293

5.  Hepatic angiomyolipoma: a retrospective study of 25 cases.

Authors:  Tao Li; Lu Wang; Hai-Hua Yu; Hui-Chuan Sun; Lun-Xiu Qin; Qing-Hai Ye; Jia Fan; Zhao-You Tang
Journal:  Surg Today       Date:  2008-05-31       Impact factor: 2.549

Review 6.  Clinical characteristics and outcomes of patients with hepatic angiomyolipoma: A literature review.

Authors:  Paul Calame; Gaëlle Tyrode; Delphine Weil Verhoeven; Sophie Félix; Anne Julia Klompenhouwer; Vincent Di Martino; Eric Delabrousse; Thierry Thévenot
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.